Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AvePoint (AVPT) EBT (2019 - 2025)

AvePoint (AVPT) has disclosed EBT for 7 consecutive years, with -$10.0 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT fell 122.24% to -$10.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.5 million, a 78.3% decrease, with the full-year FY2025 number at -$24.5 million, down 162.49% from a year prior.
  • EBT was -$10.0 million for Q4 2025 at AvePoint, down from $8.1 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $45.0 million in Q4 2024 to a low of -$15.3 million in Q3 2021.
  • A 5-year average of $1.7 million and a median of -$3.7 million in 2021 define the central range for EBT.
  • Peak YoY movement for EBT: crashed 256.85% in 2021, then skyrocketed 1519.21% in 2025.
  • AvePoint's EBT stood at $23.2 million in 2021, then tumbled by 57.47% to $9.9 million in 2022, then soared by 210.2% to $30.6 million in 2023, then skyrocketed by 47.06% to $45.0 million in 2024, then crashed by 122.24% to -$10.0 million in 2025.
  • Per Business Quant, the three most recent readings for AVPT's EBT are -$10.0 million (Q4 2025), $8.1 million (Q3 2025), and $7.1 million (Q2 2025).